590 Stock Overview
Tus-Pharmaceutical Group Co., Ltd. manufactures and sells Chinese patent medicines, chemical medicines, and health foods in China.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Tus-Pharmaceutical Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥6.29 |
| 52 Week High | CN¥11.25 |
| 52 Week Low | CN¥4.80 |
| Beta | 0.15 |
| 1 Month Change | -14.65% |
| 3 Month Change | -28.28% |
| 1 Year Change | -25.39% |
| 3 Year Change | -22.92% |
| 5 Year Change | -56.29% |
| Change since IPO | 57.57% |
Recent News & Updates
Tus-Pharmaceutical Group's (SZSE:000590) Solid Profits Have Weak Fundamentals
Apr 03
Revenues Not Telling The Story For Tus-Pharmaceutical Group Co., Ltd. (SZSE:000590) After Shares Rise 27%
Mar 08Shareholder Returns
| 590 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -15.7% | -1.5% | -0.4% |
| 1Y | -25.4% | -16.0% | -17.6% |
Return vs Industry: 000590 underperformed the CN Pharmaceuticals industry which returned -15.9% over the past year.
Return vs Market: 000590 underperformed the CN Market which returned -17.8% over the past year.
Price Volatility
| 590 volatility | |
|---|---|
| 590 Average Weekly Movement | 10.7% |
| Pharmaceuticals Industry Average Movement | 7.9% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.4% |
Stable Share Price: 000590's share price has been volatile over the past 3 months.
Volatility Over Time: 000590's weekly volatility (11%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1956 | 1,237 | Xue Feng | www.tuspharma.cn |
Tus-Pharmaceutical Group Co., Ltd. manufactures and sells Chinese patent medicines, chemical medicines, and health foods in China. The company offers Guhan health essences, Danzao oral liquids, Danhuang granules, and Yangxin Dingpalan granules. It also provides tonic health care, cardiovascular and cerebrovascular products, children's nutrition, cold products, heat-clearing, and detoxification products, etc. The company was formerly known as Tus-Guhan Group Corp.,Ltd.
Tus-Pharmaceutical Group Co., Ltd. Fundamentals Summary
| 590 fundamental statistics | |
|---|---|
| Market cap | CN¥1.51b |
| Earnings (TTM) | CN¥25.25m |
| Revenue (TTM) | CN¥404.65m |
59.7x
P/E Ratio3.7x
P/S RatioIs 590 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 590 income statement (TTM) | |
|---|---|
| Revenue | CN¥404.65m |
| Cost of Revenue | CN¥193.41m |
| Gross Profit | CN¥211.24m |
| Other Expenses | CN¥185.99m |
| Earnings | CN¥25.25m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 26, 2024
| Earnings per share (EPS) | 0.11 |
| Gross Margin | 52.20% |
| Net Profit Margin | 6.24% |
| Debt/Equity Ratio | 12.4% |
How did 590 perform over the long term?
See historical performance and comparison